SCHEMBL4510872

SCHEMBL4510872

CC(C)N1CCN(C(=O)c2[nH]c3ccccc3c2CN2CCC(c3c(Cl)cccc3Cl)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
HRH3 Q9Y5N1 8/20 0.43
MCL1 Q07820 4/20 0.42
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40
HTR2A P28223 1/20 0.40
MEN1 O00255 1/20 0.40
MAPT P10636 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 1/20 0.40
PARP1 P09874 1/20 0.40
KCNH2 Q12809 1/20 0.39
HRH4 Q9H3N8 1/20 0.38
OPRM1 P35372 1/20 0.38
OPRK1 P41145 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL4515006 0.91 MCL1 (0.40) HRH3MCL1KDM4EALDH1A1HTR2A
SCHEMBL4520883 0.90 HRH4 (0.49) MCL1KDM4EALDH1A1HTR2AMEN1
Hydrochloric Acid SCHEMBL4505439 0.90 MCL1 (0.41) MCL1KDM4EALDH1A1HTR2AMEN1
SCHEMBL4515176 0.88 LMNA (0.46) MCL1KDM4EALDH1A1HTR2AMEN1
SCHEMBL4529569 0.88 HTR2A (0.43) MCL1KDM4EALDH1A1HTR2AMEN1
Hydrochloric Acid SCHEMBL4525039 0.87 HTR2A (0.51) MCL1KDM4EALDH1A1HTR2AMEN1
SCHEMBL4528863 0.86 HTR2A (0.41) MCL1KDM4EALDH1A1HTR2AMEN1
Hydrochloric Acid SCHEMBL4522613 0.86 HTR2A (0.42) MCL1KDM4EALDH1A1HTR2AMEN1
Hydrochloric Acid SCHEMBL4504863 0.86 HRH4 (0.46) MCL1KDM4EALDH1A1HTR2AMEN1
SCHEMBL4531335 0.86 KMT2A (0.41) MCL1KDM4EALDH1A1HTR2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US claimed
EP-1841755-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2007-10-10 EP claimed
WO-2006070001-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2006-07-06 WO claimed
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor BRANE DISCOVERY S.R.L. (IT) 2009-11-05 US disclosed
EP-1841755-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2007-10-10 EP disclosed
WO-2006070001-A1 SUBSTITUTED INDOLE LIGANDS FOR THE ORL-1 RECEPTOR BRANE DISCOVERY S.R.L. (IT) 2006-07-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275555-A1 Substituted indole ligands for the ORL-1 receptor OGFRL1, OPRL1, ORMDL3 HRH3 128/4885MCL1 1303/4885KDM4E 4525/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.